Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

2023 Semi-annual Report

Aug 26, 2023 · Shanghai Stock Exchange

2023 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment